Viking Global Investors
Founded in 1999, Viking Global Investors ("Viking") is a global firm with a fundamental, research-intensive, long-term-focused approach to investing. We currently manage over $49 billion in capital.
Viking’s private healthcare team:
- Dedicated healthcare team with extensive scientific training and deep domain expertise in biotech, medtech, healthcare services and digital health
- Close collaboration with Viking’s public market team, providing more than 20 years of public investment expertise and insight
- Focused on aligning with high-quality companies and best-in-class management teams and providing financial and advisory support to help maximize long-term value as businesses scale
Track record highlights:
- $3.5B+ total capital invested in healthcare since inception
- 70+ healthcare investments since inception
- 100% Rate of IPO participation in our healthcare companies
- $20-$500M+ target deployment per investment